BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8139476)

  • 21. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size.
    Blackburn P; Côté M; Lamarche B; Couillard C; Pascot A; Tremblay A; Bergeron J; Lemieux I; Després JP
    Metabolism; 2003 Nov; 52(11):1379-86. PubMed ID: 14624394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus.
    Noutsou M; Georgopoulos A
    J Diabetes Complications; 1999; 13(2):98-104. PubMed ID: 10432174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bezafibrate therapy in patients with isolated low high-density lipoprotein cholesterol levels may have a beneficial effect in prevention of atherosclerosis.
    Weintraub MS; Grosskopf I; Charach G; Mor R; Rubinstein A; Wollman Y; Judevices R; Iaina A
    Metabolism; 1995 Nov; 44(11):1401-9. PubMed ID: 7476325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants.
    Krasinski SD; Cohn JS; Russell RM; Schaefer EJ
    Metabolism; 1990 Apr; 39(4):357-65. PubMed ID: 2325560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.
    Parhofer KG; Laubach E; Barrett PH
    J Lipid Res; 2003 Jun; 44(6):1192-8. PubMed ID: 12671031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol.
    Syvänne M; Talmud PJ; Humphries SE; Fisher RM; Rosseneu M; Hilden H; Taskinen MR
    J Lipid Res; 1997 Jul; 38(7):1463-72. PubMed ID: 9254071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia.
    Föger B; Drexel H; Hopferwieser T; Miesenböck G; Ritsch A; Lechleitner M; Tröbinger G; Patsch JR
    Clin Investig; 1994 Mar; 72(4):294-301. PubMed ID: 8043977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
    van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
    Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients.
    Guerci B; Vergès B; Durlach V; Hadjadj S; Drouin P; Paul JL
    Int J Obes Relat Metab Disord; 2000 Apr; 24(4):468-78. PubMed ID: 10805504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.
    Simo IE; Yakichuk JA; Ooi TC
    Atherosclerosis; 1993 Apr; 100(1):55-64. PubMed ID: 8318063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of apolipoprotein E isoform difference on postprandial lipoprotein in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol.
    Superko HR; Haskell WL
    Artery; 1991; 18(6):315-25. PubMed ID: 1750804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.
    Boquist S; Karpe F; Danell-Toverud K; Hamsten A
    Atherosclerosis; 2002 May; 162(1):163-70. PubMed ID: 11947910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.
    Groot PH; van Stiphout WA; Krauss XH; Jansen H; van Tol A; van Ramshorst E; Chin-On S; Hofman A; Cresswell SR; Havekes L
    Arterioscler Thromb; 1991; 11(3):653-62. PubMed ID: 2029503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a).
    Superko HR; Krauss RM
    J Am Coll Cardiol; 2000 Feb; 35(2):321-6. PubMed ID: 10676676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.
    Tan KC; Tso AW; Tam SC; Pang RW; Lam KS
    Diabet Med; 2002 Nov; 19(11):944-8. PubMed ID: 12421432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
    Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
    Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of stanol ester on postabsorptive squalene and retinyl palmitate.
    Relas H; Gylling H; Miettinen TA
    Metabolism; 2000 Apr; 49(4):473-8. PubMed ID: 10778871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses.
    O'Meara NM; Lewis GF; Cabana VG; Iverius PH; Getz GS; Polonsky KS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):465-71. PubMed ID: 1639947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice.
    Salerno AG; Patrício PR; Berti JA; Oliveira HC
    Biochem J; 2009 May; 419(3):629-34. PubMed ID: 19191759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.